183 related articles for article (PubMed ID: 35132566)
21. Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literature.
Abu-Hanna J; Patel JA; Anastasakis E; Cohen R; Clapp LH; Loizidou M; Eddama MMR
Clin Epigenetics; 2022 Aug; 14(1):98. PubMed ID: 35915507
[TBL] [Abstract][Full Text] [Related]
22. KDM6B induces epithelial-mesenchymal transition and enhances clear cell renal cell carcinoma metastasis through the activation of SLUG.
Li Q; Hou L; Ding G; Li Y; Wang J; Qian B; Sun J; Wang Q
Int J Clin Exp Pathol; 2015; 8(6):6334-44. PubMed ID: 26261509
[TBL] [Abstract][Full Text] [Related]
23. TET3 controls the expression of the H3K27me3 demethylase Kdm6b during neural commitment.
Montibus B; Cercy J; Bouschet T; Charras A; Maupetit-Méhouas S; Nury D; Gonthier-Guéret C; Chauveau S; Allegre N; Chariau C; Hong CC; Vaillant I; Marques CJ; Court F; Arnaud P
Cell Mol Life Sci; 2021 Jan; 78(2):757-768. PubMed ID: 32405722
[TBL] [Abstract][Full Text] [Related]
24. KDM6B epigenetically regulates odontogenic differentiation of dental mesenchymal stem cells.
Xu J; Yu B; Hong C; Wang CY
Int J Oral Sci; 2013 Dec; 5(4):200-5. PubMed ID: 24158144
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms of OLIG2 transcription factor in brain cancer.
Tsigelny IF; Kouznetsova VL; Lian N; Kesari S
Oncotarget; 2016 Aug; 7(33):53074-53101. PubMed ID: 27447975
[TBL] [Abstract][Full Text] [Related]
26. KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma.
D'Oto A; Fang J; Jin H; Xu B; Singh S; Mullasseril A; Jones V; Abu-Zaid A; von Buttlar X; Cooke B; Hu D; Shohet J; Murphy AJ; Davidoff AM; Yang J
Nat Commun; 2021 Dec; 12(1):7204. PubMed ID: 34893606
[TBL] [Abstract][Full Text] [Related]
27. Synergistic triad epistasis of epigenetic H3K27me modifier genes, EZH2, KDM6A, and KDM6B, in gastric cancer susceptibility.
Lee SW; Park DY; Kim MY; Kang C
Gastric Cancer; 2019 May; 22(3):640-644. PubMed ID: 30374835
[TBL] [Abstract][Full Text] [Related]
28. The histone lysine demethylase Kdm6b is required for activity-dependent preconditioning of hippocampal neuronal survival.
Wijayatunge R; Chen LF; Cha YM; Zannas AS; Frank CL; West AE
Mol Cell Neurosci; 2014 Jul; 61():187-200. PubMed ID: 24983519
[TBL] [Abstract][Full Text] [Related]
29. KDM6B Counteracts EZH2-Mediated Suppression of
Wang W; Lim KG; Feng M; Bao Y; Lee PL; Cai Y; Chen Y; Zhang H; Marzese D; Hoon DSB; Yu Q
Mol Cancer Ther; 2018 Sep; 17(9):1973-1983. PubMed ID: 29925528
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia-Mediated Regulation of Histone Demethylases Affects Angiogenesis-Associated Functions in Endothelial Cells.
Liu OH; Kiema M; Beter M; Ylä-Herttuala S; Laakkonen JP; Kaikkonen MU
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2665-2677. PubMed ID: 32938217
[TBL] [Abstract][Full Text] [Related]
31. KDM6B promotes gastric carcinogenesis and metastasis via upregulation of CXCR4 expression.
Liu F; Wang Y; Yang Z; Cui X; Zheng L; Fu Y; Shao W; Zhang L; Yang Q; Jia J
Cell Death Dis; 2022 Dec; 13(12):1068. PubMed ID: 36564369
[TBL] [Abstract][Full Text] [Related]
32. KDM6B interacts with TFDP1 to activate P53 signaling in regulating mouse palatogenesis.
Guo T; Han X; He J; Feng J; Jing J; Janečková E; Lei J; Ho TV; Xu J; Chai Y
Elife; 2022 Feb; 11():. PubMed ID: 35212626
[TBL] [Abstract][Full Text] [Related]
33. Activation of epigenetic regulator KDM6B by
Rana S; Maurya S; Mohapatra G; Singh S; Babar R; Chandrasekhar H; Chamoli G; Rathore D; Kshetrapal P; Srikanth CV
Gut Microbes; 2021; 13(1):1986665. PubMed ID: 34696686
[TBL] [Abstract][Full Text] [Related]
34. KDM6 demethylase independent loss of histone H3 lysine 27 trimethylation during early embryonic development.
Shpargel KB; Starmer J; Yee D; Pohlers M; Magnuson T
PLoS Genet; 2014 Aug; 10(8):e1004507. PubMed ID: 25101834
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugs.
Mathur R; Sehgal L; Havranek O; Köhrer S; Khashab T; Jain N; Burger JA; Neelapu SS; Davis RE; Samaniego F
Haematologica; 2017 Feb; 102(2):373-380. PubMed ID: 27742770
[TBL] [Abstract][Full Text] [Related]
36. KDM6B (JMJD3) and its dual role in cancer.
Lagunas-Rangel FA
Biochimie; 2021 May; 184():63-71. PubMed ID: 33581195
[TBL] [Abstract][Full Text] [Related]
37. Myeloid-specific KDM6B inhibition sensitizes glioblastoma to PD1 blockade.
Goswami S; Raychaudhuri D; Singh P; Natarajan SM; Chen Y; Poon C; Hennessey M; Tannir AJ; Zhang J; Anandhan S; Kerrigan BP; Macaluso MD; He Z; Jindal S; Lang FF; Basu S; Sharma P
Nat Cancer; 2023 Oct; 4(10):1455-1473. PubMed ID: 37653141
[TBL] [Abstract][Full Text] [Related]
38. Kdm6b regulates cartilage development and homeostasis through anabolic metabolism.
Dai J; Yu D; Wang Y; Chen Y; Sun H; Zhang X; Zhu S; Pan Z; Heng BC; Zhang S; Ouyang H
Ann Rheum Dis; 2017 Jul; 76(7):1295-1303. PubMed ID: 28314754
[TBL] [Abstract][Full Text] [Related]
39. Genetic variants in the KDM6B gene are associated with neurodevelopmental delays and dysmorphic features.
Stolerman ES; Francisco E; Stallworth JL; Jones JR; Monaghan KG; Keller-Ramey J; Person R; Wentzensen IM; McWalter K; Keren B; Heron B; Nava C; Heron D; Kim K; Burton B; Al-Musafri F; O'Grady L; Sahai I; Escobar LF; Meuwissen M; Reyniers E; Kooy F; Lacassie Y; Gunay-Aygun M; Schatz KS; Hochstenbach R; Zwijnenburg PJG; Waisfisz Q; van Slegtenhorst M; Mancini GMS; Louie RJ
Am J Med Genet A; 2019 Jul; 179(7):1276-1286. PubMed ID: 31124279
[TBL] [Abstract][Full Text] [Related]
40. KDM6B histone demethylase is an epigenetic regulator of estrogen receptor β expression in human pleural mesothelioma.
Manente AG; Pinton G; Zonca S; Tavian D; Habib T; Jithesh PV; Fennell D; Nilsson S; Moro L
Epigenomics; 2016 Sep; 8(9):1227-38. PubMed ID: 27529370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
